Codexis, Casdin launch SynBio Innovation Accelerator

December 2, 2020 |

In California, Codexis and Casdin Capital will launch the SynBio Innovation Accelerator. The goal of the accelerator is to fund and nurture early stage companies with disruptive technology platforms or unique product development capabilities in the far reaching and transformative field of synthetic and industrial biotechnology. Casdin Capital envisions in the next several years investing upwards of $50 million into companies tied to the industry and the SynBio Innovation Accelerator.

The first investment by the SynBio Innovation Accelerator is in a computational protein design company, Arzeda, where Codexis and Casdin are jointly making a $1.75 million investment. In addition to that capital investment, Codexis and Arzeda expect to collaborate on areas of synergy and mutual advantage. The initial focus will be on continuing the work of both companies in expanding the scope and benefit of machine learning and artificial intelligence in developing new, impactful enzymes as functional products or tools. Arzeda is an emerging player in the field of protein engineering, with a core focus on computational approaches to designing novel enzyme functionality. The Company will leverage Codexis’ existing proprietary informatics tools and its highly efficient screening and optimization workflows.

John Nicols, President and CEO of Codexis said, “Leveraging Codexis’ proven protein engineering technology and business-operational capabilities, with Casdin Capital’s financial resources, network and investment process, we will together add fuel to a now lit fire.”

Print Friendly, PDF & Email

Category: Fuels

Thank you for visting the Digest.